Header Logo

Connection

DAVID GRAHAM to Anti-Inflammatory Agents, Non-Steroidal

Back to Details
This is a "connection" page, showing publications DAVID GRAHAM has written about Anti-Inflammatory Agents, Non-Steroidal.
DAVID GRAHAM
Connection Strength
4.918
Anti-Inflammatory Agents, Non-Steroidal
  1. Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply. Aliment Pharmacol Ther. 2018 06; 47(11):1546-1547.
    View in: PubMed
    Score: 0.509
  2. Inaccurate endoscopy: a better explanation for placebo-associated endoscopic ulcers. Aliment Pharmacol Ther. 2009 Nov 01; 30(9):955-7; author reply 957-60.
    View in: PubMed
    Score: 0.281
  3. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology. 2008 Apr; 134(4):1240-6.
    View in: PubMed
    Score: 0.252
  4. NSAIDs and gastrointestinal complications: new clinical challenges. Expert Opin Pharmacother. 2005 Dec; 6(15):2681-9.
    View in: PubMed
    Score: 0.214
  5. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005 Jan; 3(1):55-9.
    View in: PubMed
    Score: 0.201
  6. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61.
    View in: PubMed
    Score: 0.192
  7. NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med. 2002 Dec 26; 347(26):2162-4.
    View in: PubMed
    Score: 0.175
  8. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8.
    View in: PubMed
    Score: 0.164
  9. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med. 2002 Jan 28; 162(2):169-75.
    View in: PubMed
    Score: 0.164
  10. NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci. 2002 Jan; 47(1):38-43.
    View in: PubMed
    Score: 0.163
  11. Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5):775-85.
    View in: PubMed
    Score: 0.160
  12. Alendronate and naproxen are synergistic for development of gastric ulcers. Arch Intern Med. 2001 Jan 08; 161(1):107-10.
    View in: PubMed
    Score: 0.152
  13. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S.
    View in: PubMed
    Score: 0.152
  14. Low-dose aspirin may or may not damage the gastric mucosa. Gastroenterology. 1999 Dec; 117(6):1505.
    View in: PubMed
    Score: 0.141
  15. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen,?or?Ibuprofen. J Am Coll Cardiol. 2018 04 24; 71(16):1741-1751.
    View in: PubMed
    Score: 0.126
  16. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018 06; 47(11):1453-1463.
    View in: PubMed
    Score: 0.126
  17. Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial. Arthritis Rheumatol. 2018 04; 70(4):537-546.
    View in: PubMed
    Score: 0.126
  18. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21; 38(44):3282-3292.
    View in: PubMed
    Score: 0.123
  19. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol. 1997 Aug; 92(8):1322-5.
    View in: PubMed
    Score: 0.120
  20. Histological features do not define NSAID-induced gastritis. Hum Pathol. 1996 Dec; 27(12):1348-54.
    View in: PubMed
    Score: 0.115
  21. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29.
    View in: PubMed
    Score: 0.114
  22. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol. 1996 Oct; 91(10):2080-6.
    View in: PubMed
    Score: 0.113
  23. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy. 1996 Feb; 28(2):229-33.
    View in: PubMed
    Score: 0.108
  24. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion. 2012; 86(2):171-7.
    View in: PubMed
    Score: 0.085
  25. Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation. Am J Med Sci. 2011 Nov; 342(5):356-64.
    View in: PubMed
    Score: 0.081
  26. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991 Jun; 100(6):1653-7.
    View in: PubMed
    Score: 0.078
  27. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol Clin North Am. 1990 Mar; 19(1):171-82.
    View in: PubMed
    Score: 0.072
  28. Dyspepsia in NSAID users: the size of the problem. J Clin Gastroenterol. 1989 Apr; 11(2):158-62.
    View in: PubMed
    Score: 0.067
  29. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol. 1988 Oct; 83(10):1081-4.
    View in: PubMed
    Score: 0.065
  30. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol. 1987 Nov; 82(11):1153-8.
    View in: PubMed
    Score: 0.061
  31. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions. Aliment Pharmacol Ther. 2007 Feb 01; 25(3):345-6; author reply 346-7.
    View in: PubMed
    Score: 0.058
  32. Pathogenesis and therapy of gastric and duodenal ulcer disease. Med Clin North Am. 2002 Nov; 86(6):1447-66, viii.
    View in: PubMed
    Score: 0.043
  33. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
    View in: PubMed
    Score: 0.043
  34. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci. 2002 Aug; 47(8):1665-78.
    View in: PubMed
    Score: 0.042
  35. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999 Nov 24; 282(20):1921-8.
    View in: PubMed
    Score: 0.035
  36. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications. Gen Dent. 1999 Nov-Dec; 47(6):590-6; quiz 597-8.
    View in: PubMed
    Score: 0.035
  37. Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial. Am J Gastroenterol. 2018 07; 113(7):1053-1054.
    View in: PubMed
    Score: 0.032
  38. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995 Aug 15; 123(4):241-9.
    View in: PubMed
    Score: 0.026
  39. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012 May; 61(5):646-64.
    View in: PubMed
    Score: 0.021
  40. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991 Aug 15; 115(4):266-9.
    View in: PubMed
    Score: 0.020
  41. Gastritis in the elderly. Gastroenterol Clin North Am. 1990 Jun; 19(2):273-92.
    View in: PubMed
    Score: 0.018
  42. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol. 1989 Mar; 84(3):233-8.
    View in: PubMed
    Score: 0.017
  43. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009 Apr; 157(4):606-12.
    View in: PubMed
    Score: 0.017
  44. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des. 2000 Oct; 6(15):1503-14.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.